Reporter

Alzheimer’s genetic risk tracked across sex, race

A Vanderbilt study of genetic risks for cognitive impairment later in life uses data from 32,426 research participants ages 60 and older to elaborate these risks across sex and across the intersection of sex and race.

World-first clinical trial to help millions with penicillin allergies

Many low-risk patients with a penicillin allergy were able to have their penicillin allergy label removed through a simple procedure known as “direct oral challenge” as part of a world-first multicenter randomized control trial known as the Penicillin Allergy Clinical Decision Rule (PALACE) study.

Hogan named to American Society for Clinical Pathology ‘40 Under Forty’ list

Vanderbilt’s Melissa Straub Hogan, MD, has been named to the 2023 American Society for Clinical Pathology 40 Under Forty list.

Study uses statistical and population-based methods to understand comorbidities of developmental language disorder

A recent Vanderbilt study is one of the first to use statistical and population-based methods to understand comorbidities associated with developmental language disorder at a population level.

Grant renewal strengthens patient-centered outcomes research training program

The federal government has renewed its support of a learning healthcare system (LHS) T32 training program at Vanderbilt University Medical Center that prepares investigators to discover, evaluate and implement strategies for improving patient outcomes and, ultimately, the overall health of the community.

syringe

VIGH, partners get training grant to create vaccine-related research in Peru

In partnership with the Universidad Peruana Cayetano Heredia (UPCH) and the Instituto de Investigacion Nutricional (IIN), the Vanderbilt Institute for Global Health (VIGH) has received $1.2 million for a five-year training grant funded by the Fogarty International Center to establish the Peru-Vanderbilt Prevention through Vaccination Training program.

1 32 33 34 35 36 770